A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial
Part of paid clinical trials in Seattle, Washington.
- Sponsor
- Fred Hutchinson Cancer Center
- Study ID
- NCT06145763
- Status
- Recruiting
Conditions
- Cigarette Smoking-Related Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Biospecimen Collection — PROCEDUREAncillary studies
- Smoking Cessation Intervention — BEHAVIORALUse IndigeQuit smartphone app
- Smoking Cessation Intervention — BEHAVIORALUse NCI QuitGuide smartphone app
- Survey Administration — OTHERAncillary studies
Study Details
This clinical trial compares a new smoking cessation smartphone application (app) (IndigeQuit) to an existing smarphone app (National Cancer Institute \[NCI\] QuitGuide) for helping American Indians and Alaska Natives (AI/ANs) quit smoking. Compared to other racial/ethnic groups, AIANs have 6 times higher rates of developing smoking-related cancers, including lung cancer. Commercial cigarette smoking accounts for half of all deaths among AIANs nationwide. AIANs' often lack of access to smoking cessation interventions, which may be due to inequities in the healthcare system, lack of health insurance, living in rural areas, systemic racism, and historical trauma. There is also a lack of effective smoking cessation interventions for AIANs. Smartphone apps have the potential to deliver a low-cost smoking cessation intervention with wide reach to AIANs. Apps require no in-person delivery and no provider training, do not require integration into complex hospital systems, can be freely accessed on an app store, and are available at any time and any place. IndigeQuit is a behavioral intervention designed to help adults stop smoking by teaching skills for coping with smoking urges, staying motivated, and preventing relapse. The IndigeQuit app intervention may be more effective than the currently available NCI QuitGuide app at helping AIANs quit smoking.
Key Dates
- Start date
- Jul 3, 2025
- Status verified
- Feb 2026
- Primary completion
- Nov 30, 2027
- Completion
- Nov 30, 2028
Study Design
- Enrollment
- 776 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Arm I (IndigeQuit app)Participants use the IndigeQuit app, which includes setting up a personalized quit plan, participating in eight levels of the content, receiving on-demand help in coping with smoking urges, and tracking their daily smoking behaviors for at least 45 days on study.
- Active Comparator: Arm II (NCI QuitGuide app)Participants use the NCI QuitGuide app for at least 45 days on study.
Primary Outcome Measure
30-day point prevalence abstinence (PPA) [ Time Frame: At 12 months post randomization ]
Central Contacts
- Brie Sullivan206-667-5238
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Fred Hutch/University of Washington Cancer Consortium | Seattle | Washington | 98109 | Jonathan B. Bricker (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Seattle, WA
Related Studies
- A Smartphone Application (QuitBot) for the Improvement of Smoking Cessation Among American Indians and Alaska Natives, NAITIVE TrialNot Yet Recruiting · Fred Hutchinson Cancer Center · Seattle, Washington
- iCanQuit Smoking Cessation Among Hispanic AdultsPHASE3 · Not Yet Recruiting · Fred Hutchinson Cancer Center · Seattle, Washington
- A Behavioral Application for Improving Smoking Cessation Among SmokersNot Yet Recruiting · Fred Hutchinson Cancer Center · Seattle, Washington
- Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I TrialPHASE4 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas